ArticleACS catalysis2025
Discovery of UbiA-Type Cyathane Synthases in Bacteria.
Article in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigations of the Evolved Molecular Basis for Terpenoid Biosynthesis in Marine Sponges.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
UbiA-type terpene synthases, traditionally annotated as prenyltransferases, have been shown to catalyze terpene cyclization in recent years, expanding their catalytic repertoire beyond primary metabolism. Here, we report on the genome-guided discovery and functional characterization of bacterial UbiA diterpene synthases (diTSs). Using a geranylgeranyl diphosphate (GGPP)-overproducing E. coli system, we screened 32 candidate enzymes and identified five that generate structurally diverse diterpenes, two of which represent bacterial examples of cyathane synthases. Site-directed mutagenesis uncovered active-site residues that influence product formation, directing cyclization towards mono- or tricyclic products. This study expands the known catalytic repertoire of UbiA enzymes and highlights their untapped potential in bacterial terpenoid biosynthesis. Our findings suggest that bacteria may produce diverse and bioactive diterpenoids using UbiA TSs for the first committed biosynthetic step, warranting further exploration of UbiA TSs for natural product discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.